"
Accelerate Myasthenia Gravis research with validated antibodies, recombinant proteins, and assay kits targeting established and emerging disease biomarkers and therapeutic targets. RUO
Download product datasheets, validation images (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.
We offer validated antibodies, recombinant proteins, and ELISA kits targeting established and emerging biomarkers relevant to this disease area.
All reagents are Research Use Only (RUO), produced under ISO quality systems, and widely used in translational biomarker discovery and preclinical studies.
Yes — many products are cited in peer-reviewed publications. Visit our References page to search by target name or catalog number.
Our parent company AtaGenix offers full custom antibody development from immunogen design through hybridoma production and characterization.
Use our target search to filter by application, species, and conjugation. Our technical team is also available to provide personalized recommendations.
"
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, FCM, WB, IHC, IF
Human
IgG1, kappa
SAA2008
Human
ELISA, FCM, WB
Human
IgG4, kappa
SAA2009
Human
FCM
Human
IgG1, lambda
BlySmAb-1.1
Human
FCM
Human
IgG4, kappa
SAA0136
Human
FCM
Human
IgG4, kappa
SAA0135
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-lambda